Mathilde Goudot

741 total citations
5 papers, 388 citations indexed

About

Mathilde Goudot is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Mathilde Goudot has authored 5 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 2 papers in Infectious Diseases. Recurrent topics in Mathilde Goudot's work include Multiple Sclerosis Research Studies (3 papers), Autoimmune Neurological Disorders and Treatments (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Mathilde Goudot is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Autoimmune Neurological Disorders and Treatments (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Mathilde Goudot collaborates with scholars based in France. Mathilde Goudot's co-authors include Nicolas Collongues, J. de Sèze, Kévin Bigaut, Catherine Lubetzki, David Laplaud, Alain Créange, Caroline Papeix, Bruno Stankoff, C. Giannesini and Romain Deschamps and has published in prestigious journals such as JAMA Neurology, Journal of Neurology and Multiple Sclerosis Journal.

In The Last Decade

Mathilde Goudot

5 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mathilde Goudot France	4	262	254	225	85	36	5	388
Nada Abou-Fayssal United States	5	122 0.5×	89 0.4×	119 0.5×	55 0.6×	26 0.7×	7	247
Gustavo Luna United States	3	272 1.0×	112 0.4×	149 0.7×	88 1.0×	7 0.2×	4	363
Caroline Bensa France	4	182 0.7×	59 0.2×	126 0.6×	44 0.5×	11 0.3×	8	230
Polina Sonis Israel	8	269 1.0×	320 1.3×	162 0.7×	61 0.7×	4 0.1×	14	443
Jeanette Wendt United States	4	248 0.9×	139 0.5×	126 0.6×	78 0.9×	2 0.1×	5	326
Jean-Louis Fergé Martinique	5	172 0.7×	76 0.3×	174 0.8×	12 0.1×	17 0.5×	5	325
Jenny Huang United States	5	198 0.8×	101 0.4×	68 0.3×	248 2.9×	6 0.2×	7	368
Joela Mathews United Kingdom	8	164 0.6×	50 0.2×	53 0.2×	59 0.7×	3 0.1×	21	220
Stella Hughes United Kingdom	6	88 0.3×	29 0.1×	42 0.2×	13 0.2×	16 0.4×	11	134
Asma Boumaza France	8	52 0.2×	162 0.6×	67 0.3×	16 0.2×	5 0.1×	10	288

Countries citing papers authored by Mathilde Goudot

Since Specialization

Citations

This map shows the geographic impact of Mathilde Goudot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Goudot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Goudot more than expected).

Fields of papers citing papers by Mathilde Goudot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Goudot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Goudot. The network helps show where Mathilde Goudot may publish in the future.

Co-authorship network of co-authors of Mathilde Goudot

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Goudot. A scholar is included among the top collaborators of Mathilde Goudot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Goudot. Mathilde Goudot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Bigaut, Kévin, Laurent Kremer, Thibaut Fabacher, et al.. (2022). Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study. Journal of Neurology. 269(6). 3295–3300. 12 indexed citations

2.

Goudot, Mathilde, Lucie Hopes, Antoine Verger, et al.. (2021). Recurrent seizures of autoimmune origin: emerging phenotypes. Journal of Neurology. 268(8). 3000–3010. 1 indexed citations

3.

Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. Multiple Sclerosis Journal. 26. 49–50. 84 indexed citations

4.

Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurology. 77(9). 1079–1079. 287 indexed citations

5.

Goudot, Mathilde, Solène Frismand, Lucie Hopes, et al.. (2019). GAD65‐Ab encephalitis and subtle focal status epilepticus. Epileptic Disorders. 21(5). 437–442. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact